期刊文献+

人内皮抑素在大肠杆菌中的高效表达及活性研究 被引量:1

High efficient expression of human endostatin in E.coli and its antiangiogensis activity
在线阅读 下载PDF
导出
摘要 目的 :表达人内皮抑素蛋白 ,制备多克隆抗体 ,检测其生物学活性。方法 :采用PCR法扩增人内皮抑素基因 ,构建pGEX -ES融合表达载体 ,IPTG(异丙基硫代 - β-D半乳糖苷 )诱导表达。初步纯化的内皮抑素包含体蛋白制备兔多克隆抗体 ,Western -blot检测其在小鼠肝、肾等的表达。亲和纯化的内皮抑素蛋白用内皮细胞抑制实验检测其生物学活性。结果 :诱导表达的人内皮抑素蛋白经凝血酶酶切后 ,分子量约为 2 0kD ,具有抑制内皮细胞生长的活性。制备的多克隆抗体检测出内皮抑素在小鼠肝、肾等组织的表达。结论 AIM: To examine the expression of human endostatin in E.coli , produce its fusion protein antibody and observe its biological activity. METHODS: Endostatin gene was amplified by polymerase chain reaction,recombined with plasmid vector pGEX-2T and induced expression with IPTG.The protein activity was tested by endothelial cell proliferation inhibitory assay.Inclusion body crudely purified was used to generate polyclonal antibody to detect its expression at mouse's liver and kidney etc. RESULTS: The protein expressed was 20 kD after digestion by thrombin,it appeared the anti-angiogenesis activity and Western blotting indicated the expression of endostatin in liver and kidney of mouse. CONCLUSION: The successful expression of human endostatin and the preparation of polycolonal antibody indicated its potential application in anti-angiogenesis therapy and diagnosis tumors.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2002年第11期1370-1373,共4页 Chinese Journal of Pathophysiology
基金 国家教委留学回国人员启动基金资助项目(2 0 0 0 - 4 79)
关键词 内皮抑素 大肠杆菌 抗体 生物学活性 PCR法 实体瘤 单克隆抗体 Endostatin Antibodies Biological activity
  • 相关文献

参考文献1

二级参考文献4

  • 1C.W.迪芬巴赫 G.S.德维克斯勒.PCR技术实验指南[M].北京:科学出版社,1998.71,49,207-208.
  • 2迪芬巴赫 C W,PCR技术实验指南,1998年,29页
  • 3O'Reilly M S,Cell,1997年,88卷,2期,227页
  • 4Suk P,Genomics,1994年,19卷,494页

同被引文献14

  • 1O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth [J].Cell, 1997, 88:277.
  • 2Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J]. Nature, 1997,390: 404.
  • 3James P, Thomas, Rhoda Z, etal. Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors [J]. J Clinl Oncology, 2003, 21(2): 223.
  • 4Roy S, Herbst, Nizar A, et al. Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin[J]. Journal of Clinical Oncology, 2002, 20(18): 3804.
  • 5Christoph M, James P, Thomas, et al. Tissue Examination to Monitor Antiangiogenic Therapy [J]. Clin Cancer Res,2001, 7:3366.
  • 6Xiaojun H, Michael KK Wong, Qun Z, et al. Soluble Recombinant Endostatin Purified from Escherichia coli: Antiangiogenic Activity and Antitumor Effect [J]. Cancer Res,2001,61: 478.
  • 7Dhanabal M, Ramchandran R, Volk R, et al. Endostatin:yeast production, mutants, and antitumor effect in renal cell carcinoma[J]. CancerRes, 1999, 59: 189.
  • 8Watergam HR, Digan ME, Koutz PJ, etal. Isolation of the Pichia pastores glyceraldehydes-3-phisphate degydrogenase gene and regulation and use of its promoter[J]. Gene, 1997,186: 37.
  • 9Sasaki T, Fukai N, Mam K, et al. Structure, function and tissue forms of the c-terminal globular domain of collagen ⅩⅤⅢ containing the angiogenesis inhibitor endostatin[J]. EMBO J, 1998,17:4249.
  • 10Thomas B, Michael S, O'Reilly, et al. Zinc-binding of En dostatin is essiential for its antiangiogenic activity [J].Bilchem Biophys Res Commun, 1998,252: 190.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部